Antonia Salud Salvia

Bielsa, S.; Panades, M. J.; Egido, R.; Rue, M.; Salud, A.; Matias-Guiu, X.; Rodriguez-Panadero, F.; Porcel, J. M.

ACCURaCY OF PLEURaL FLUID CYTOLOGY IN MaLIGNaNT EFFUSIONS

Anales De Medicina Interna 25 173-177. 01/04/2008.

Porcel, JM; Salud, A; Nabal, M; Vives, M; Esquerda, A; Rodriguez-Panadero, F

Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions.

SUPPORTIVE CARE IN CANCER 14 475-478. 01/05/2006.

[doi:10.1007/s00520-005-0001-x]

Feliu, J; Salud, A; Escudero, P; Lopez-Gomez, L; Bolanos, M; Galan, A; Vicent, JM; Yubero, A; Losa, F; De Castro, J; de Mon, MA; Casado, E; Gonzalez-Baron, M; Oncopaz Cooperative Grp

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

BRITISH JOURNAL OF CANCER 94 969-975. 10/04/2006.

[doi:10.1038/sj.bjc.6603047]

Valentí Moreno V; Brunet Vidal J; Manzano Alemany H; Salud Salvia A; Llobera Serentill M; Cabezas Montero I; Servitja Tormo S; Sopena Bert E; Gumà Padró J

Prevention of irinotecan associated diarrhea by intestinal alkalization. A pilot study in gastrointestinal cancer patients.

CLINICAL & TRANSLATIONAL ONCOLOGY 8 208-212. 01/03/2006.

Munoz, Alberto; Salud, Antonieta; Garcia Giron, Carlos; Murias, Adolfo; Burillo, Miguel A.; Arizcun, Alberto; Gutierrez, David; Pujol, Eduardo

Randomised phase III trial comparing irinotecan plus capecitabine (XELIRI Regimen) vs. irinotecan, 5-Fu and folinic acid (Saltz regimen) as first-line treatment in patients (PTS) with metastatic colorectal cancer (MCRC)

ANNALS OF ONCOLOGY 17 120-120. 01/01/2006.

Escudero, Pilar; Alonso, Vicente; Salud, Antonieta; Lambea, Julio; Valencia, Javier; Mira, Moises; Polo, Sonia; Lao, Juan; Sierra, E.; Anton, Antonio

Preoperative radiochemotherapy with oxaliplatin and capecitabine in resectable rectal carcinoma: Preliminary results

ANNALS OF ONCOLOGY 17 285-285. 01/01/2006.

Feliu, J; Castanon, C; Salud, A; Mel, JR; Escudero, P; Pelegrin, A; Lopez-Gomez, L; Ruiz, M; Gonzalez, E; Juarez, F; Lizon, J; Castro, J; Gonzalez-Baron, M; Oncopaz Cooperative Grp

Phase II randomised trial of raltitrexed-oxaliplatin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer

BRITISH JOURNAL OF CANCER 93 1230-1235. 28/11/2005.

[doi:10.1038/sj.bjc.6602860]

Porcel, JM; Salud, A; Vives, M; Esquerda, A; Rodriguez-Panadero, F

Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.

CLINICAL BIOCHEMISTRY 38 1031-1033. 01/11/2005.

[doi:10.1016/j.clinbiochem.2005.05.001]

Salud, A.; Escudero, P.; Feliu, J.; Lopez-Gomez, L.; Bolanos, M.; Galan, A.; Yubero, A.; Vicent, J. M.; Losa, F.; Gonzalez-Baron, M.

Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC)

Ejc Supplements 3 190-190. 01/10/2005.

Nogue, M; Salud, A; Batiste-Alentorn, E; Saigi, E; Losa, F; Cirera, L; Mendez, M; Campos, JM; Galan, A; Escudero, P; Arcusa, A; Manzano, H; de Mendizabal, EV; de Olaguer, JP; Boleda, M; Guasch, I; Vicente, P

Randornised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer

EUROPEAN JOURNAL OF CANCER 41 2241-2249. 01/10/2005.

[doi:10.1016/j.ejca.2005.07.013]

Alonso, V; Salud, A; Escudero, P; Bueso, P; Mira, M; Valencia, J; Polo, S; de Lobera, AR; Lao, J; Lastra, R

Phase II trial of preoperative chemoradiotherapy with irinotecan and infusional 5-fluorouracil in locally advanced operable rectal carcinoma.

Journal of Clinical Oncology 23 256-256. 01/06/2005.

Saigi, E; Batiste-Alentorn, E; Diaz, N; Galan, A; Salud, A; Campos, JM; Losa, F; Gallen, M; Massuti, B; Asensio, D

Phase II study of weekly irinotecan (CPT-11) associated to protracted oral tegafur (TGF) in previously untreated, advanced colorectal cancer (aCRC)

Journal of Clinical Oncology 23 302-302. 01/06/2005.